A decision-ready blueprint
A business development and partnering solution designed around the commercial realities of academic technology transfer offices and research centers.
Scientific, commercial, and digital architecture, with specialist expertise assembled where the engagement requires it.
Academic medical and translational centres need a disciplined path from research evidence and intellectual property to the partners, licensees, and commercialisation opportunities that can advance a programme. That work involves distinct institutional responsibilities, research context, partner questions, and approval points that should remain visible throughout the engagement.
Lonrú Consulting designs the partnering architecture around those decisions. We connect the approved research, IP, translational, market, and partner information needed to assess opportunities, prepare a credible external narrative, and manage the next accountable action.
We define the approved research, IP, translational, clinical, market, partner, and institutional sources relevant to the selected commercialisation or engagement question.
Configured systems can structure evidence, prepare opportunity material, compare defined partner criteria, or support repeatable analysis within the agreed information and review boundaries.
Lonrú provides principal-led strategy, commercial framing, and review governance. Research leads, technology-transfer professionals, institutional decision-makers, and client-selected specialists review work within their accountable areas.
Approved work can be delivered through an opportunity workspace, partner-readiness view, controlled data room, portfolio interface, or decision briefing environment.
Relate the approved research, IP, translational evidence, market context, and partner questions that shape an opportunity assessment.
Organise the evidence, assumptions, review needs, and next actions required to prepare an opportunity for a prospective licensee or strategic collaborator.
Design a practical route for preparing, reviewing, and sharing selected opportunity material while respecting institutional approval and information boundaries.
Bring the relevant landscape, partner, and opportunity signals into a decision view that helps technology-transfer and research leaders prioritise the next action.
The architecture works with the institution's own research, IP, publication, and commercialisation responsibilities. It does not publish confidential research, make unapproved claims, or replace the decisions held by researchers and technology-transfer teams.
We define the information that can be prepared for partner engagement, the approval points required before external sharing, and the people who remain accountable for the final decision.
Relevant experience
Preclinical to IND
Created interactive Preclinical-to-IND decision-tree frameworks and risk-mitigation reports to help advanced-therapy enabling-technology companies align product capabilities with FDA IND validation requirements and reduce preclinical translation delays.
Audit-ready
Formulated Technical Dossier Authoring frameworks that automate ingestion and structure of preclinical data pipelines for FDA IND and BLA submissions, producing organized, audit-ready regulatory dossiers.
Architecture in context
Diagram summary: Research, IP, translational, market, and partner evidence is contextualised, analysed, and tested through ActiveArchitecture™ before it supports a commercialisation or licensing decision.
Practical questions
Next step
Bring the decision, workflow, or delivery constraint that needs a clearer operating path.
Request a focused briefing